首页> 外文期刊>Cardiovascular Research >Uncoupling of myofilament Ca2+ sensitivity from troponin I phosphorylation by mutations can be reversed by epigallocatechin-3-gallate
【24h】

Uncoupling of myofilament Ca2+ sensitivity from troponin I phosphorylation by mutations can be reversed by epigallocatechin-3-gallate

机译:Epigallocatechin-3-gallate可逆转突变引起的肌丝Ca2 +敏感性与肌钙蛋白I磷酸化的解偶联

获取原文
获取原文并翻译 | 示例
           

摘要

Aims Heart muscle contraction is regulated via the b-adrenergic response that leads to phosphorylation of Troponin I (TnI) at Ser22/23, which changes the Ca2+ sensitivity of the cardiac myofilament. Mutations in thin filament proteins that cause dilated cardiomyopathy (DCM) and some mutations that cause hypertrophic cardiomyopathy (HCM) abolish the relationship between TnI phosphorylation and Ca2+ sensitivity (uncoupling). Small molecule Ca2+ sensitizers and Ca2+ desensitizers that act upon troponin alter the Ca2+ sensitivity of the thin filament, but their relationship with TnI phosphorylation has never been studied before.
机译:目的通过b-肾上腺素能应答来调节心肌收缩,该反应会导致肌钙蛋白I(TnI)在Ser22 / 23处磷酸化,从而改变心肌肌丝的Ca2 +敏感性。引起扩张型心肌病(DCM)的细丝蛋白突变和导致肥厚型心肌病(HCM)的某些突变消除了TnI磷酸化与Ca2 +敏感性(解偶联)之间的关系。作用于肌钙蛋白的小分子Ca2 +敏化剂和Ca2 +脱敏剂改变了细丝的Ca2 +敏感性,但是它们与TnI磷酸化的关系从未被研究过。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号